Genome sequencing of idiopathic pulmonary fibrosis in conjunction with a medical school human anatomy course

PLoS ONE

Volumn 9, Issue 9, 2014, Pages

  Kumar, Akash ^a,b   Dougherty, Max ^a,b   Findlay, Gregory M ^a,b   Geisheker, Madeleine ^a,b   Klein, Jason ^a,b   Lazar, John ^a,b   Machkovech, Heather ^a,b   Resnick, Jesse ^a,b   Resnick, Rebecca ^a,b   Salter, Alexander I ^a,b   Talebi Liasi, Faezeh ^a   Arakawa, Christopher ^a,b   Baudin, Jacob ^a,b   Bogaard, Andrew ^a,b   Salesky, Rebecca ^a   Zhou, Qian ^a   Smith, Kelly ^b   Clark, John I ^b   Shendure, Jay ^b   Horwitz, Marshall S ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MUCIN 5B; MUC5B PROTEIN, HUMAN;

ADULT; ANATOMICAL VARIATION; ARTICLE; CADAVER; CASE REPORT; COURSE CONTENT; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE MARKER; FIBROSING ALVEOLITIS; GENE; GENE FUNCTION; GENE IDENTIFICATION; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC CODE; GENETIC VARIABILITY; HUMAN; HUMAN GENOME; HUMAN TISSUE; MALE; MEDICAL SCHOOL; MEDICAL STUDENT; MICROSCOPY; MIDDLE AGED; MOLECULAR PATHOLOGY; MUC5B GENE; PREDICTION; PROMOTER REGION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; ANATOMY; CAUCASIAN; DNA SEQUENCE; EDUCATION; GENETICS; HIGH THROUGHPUT SEQUENCING; MEDICAL EDUCATION; PATHOLOGY; PROCEDURES;

ANATOMY; CADAVER; EDUCATION, MEDICAL; EUROPEAN CONTINENTAL ANCESTRY GROUP; GENOME, HUMAN; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; HUMANS; IDIOPATHIC PULMONARY FIBROSIS; MALE; MIDDLE AGED; MUCIN-5B; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84906996747     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0106744     Document Type: Article

References (54)

1. Worthey EA, Mayer AN, Syverson GD, Helbling D, Bonacci BB, et al. (2011) Making a definitive diagnosis: successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet Med 13: 255-262.
2. Dixon-Salazar TJ, Silhavy JL, Udpa N, Schroth J, Bielas S, et al. (2012) Exome sequencing can improve diagnosis and alter patient management. Sci Transl Med 4: 138ra178.
3. Lupski JR, Reid JG, Gonzaga-Jauregui C, Rio Deiros D, Chen DC, et al. (2010) Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N Engl J Med 362: 1181-1191.
4. Ashley EA, Butte AJ, Wheeler MT, Chen R, Klein TE, et al. (2010) Clinical assessment incorporating a personal genome. Lancet 375: 1525-1535.
5. Topol EJ (2013) From dissecting cadavers to dissecting genomes. Sci Transl Med 5: 202ed215.
6. Noble PW, Barkauskas CE, Jiang D (2012) Pulmonary fibrosis: patterns and perpetrators. J Clin Invest 122: 2756-2762.
7. Selman M, Pardo A (2002) Idiopathic pulmonary fibrosis: an epithelial/fibroblastic cross-talk disorder. Respir Res 3: 3.
8. Boucher RC (2011) Idiopathic pulmonary fibrosis-a sticky business. N Engl J Med 364: 1560-1561.
9. Herazo-Maya JD, Kaminski N (2012) Personalized medicine: applying 'omics' to lung fibrosis. Biomark Med 6: 529-540.
10. Noth I, Zhang Y, Ma SF, Flores C, Barber M, et al. (2013) Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study. Lancet Respir Med 1: 309-317.
11. Seibold MA, Wise AL, Speer MC, Steele MP, Brown KK, et al. (2011) A common MUC5B promoter polymorphism and pulmonary fibrosis. N Engl J Med 364: 1503-1512.
12. Hunninghake GM, Hatabu H, Okajima Y, Gao W, Dupuis J, et al. (2013) MUC5B promoter polymorphism and interstitial lung abnormalities. N Engl J Med 368: 2192-2200.
13. Fingerlin TE, Murphy E, Zhang W, Peljto AL, Brown KK, et al. (2013) Genome-wide association study identifies multiple susceptibility loci for pulmonary fibrosis. Nat Genet 45: 613-620.
14. Zhang Y, Noth I, Garcia JG, Kaminski N (2011) A variant in the promoter of MUC5B and idiopathic pulmonary fibrosis. N Engl J Med 364: 1576-1577.
15. Kropski JA, Lawson WE, Young LR, Blackwell TS (2013) Genetic studies provide clues on the pathogenesis of idiopathic pulmonary fibrosis. Dis Model Mech 6: 9-17.
16. Borie R, Crestani B, Dieude P, Nunes H, Allanore Y, et al. (2013) The MUC5B variant is associated with idiopathic pulmonary fibrosis but not with systemic sclerosis interstitial lung disease in the European Caucasian population. PLoS One 8: e70621.
17. DePristo MA, Banks E, Poplin R, Garimella KV, Maguire JR, et al. (2011) A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat Genet 43: 491-498.
18. Li H, Durbin R (2009) Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics 25: 1754-1760.
19. McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, et al. (2010) The Genome Analysis Toolkit: a MapReduce framework for analyzing nextgeneration DNA sequencing data. Genome Res 20: 1297-1303.
20. Ng SB, Turner EH, Robertson PD, Flygare SD, Bigham AW, et al. (2009) Targeted capture and massively parallel sequencing of 12 human exomes. Nature 461: 272-276.
21. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, et al. (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46: 310-315.
22. Johnson AD, Handsaker RE, Pulit SL, Nizzari MM, O'Donnell CJ, et al. (2008) SNAP: a web-based tool for identification and annotation of proxy SNPs using HapMap. Bioinformatics 24: 2938-2939.
23. Kim TS, Lee KS, Chung MP, Han J, Park JS, et al. (1998) Nonspecific interstitial pneumonia with fibrosis: high-resolution CT and pathologic findings. AJR Am J Roentgenol 171: 1645-1650.
24. Ito I, Nagai S, Kitaichi M, Nicholson AG, Johkoh T, et al. (2005) Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study. Am J Respir Crit Care Med 171: 632-638.
25. du Bois R, King TE Jr (2007) Challenges in pulmonary fibrosis x 5: the NSIP/UIP debate. Thorax 62: 1008-1012.
26. Stergachis AB, Haugen E, Shafer A, Fu W, Vernot B, et al. (2013) Exonic transcription factor binding directs codon choice and affects protein evolution. Science 342: 1367-1372.
27. Peljto AL, Zhang Y, Fingerlin TE, Ma SF, Garcia JG, et al. (2013) Association between the MUC5B promoter polymorphism and survival in patients with idiopathic pulmonary fibrosis. Jama 309: 2232-2239.
28. Yang IV, Coldren CD, Leach SM, Seibold MA, Murphy E, et al. (2013) Expression of cilium-associated genes defines novel molecular subtypes of idiopathic pulmonary fibrosis. Thorax 68: 1114-1121.
29. Turner J, Jones CE (2009) Regulation of mucin expression in respiratory diseases. Biochem Soc Trans 37: 877-881.
30. Roy MG, Livraghi-Butrico A, Fletcher AA, McElwee MM, Evans SE, et al. (2014) Muc5b is required for airway defence. Nature 505: 412-416.
31. Baumgartner KB, Samet JM, Stidley CA, Colby TV, Waldron JA (1997) Cigarette smoking: a risk factor for idiopathic pulmonary fibrosis. Am J Respir Crit Care Med 155: 242-248.
32. Marten K, Milne D, Antoniou KM, Nicholson AG, Tennant RC, et al. (2009) Non-specific interstitial pneumonia in cigarette smokers: a CT study. Eur Radiol 19: 1679-1685.
33. Cooper GM, Shendure J (2011) Needles in stacks of needles: finding diseasecausal variants in a wealth of genomic data. Nat Rev Genet 12: 628-640.
34. Poletti V, Romagnoli M, Piciucchi S, Chilosi M (2012) Current status of idiopathic nonspecific interstitial pneumonia. Semin Respir Crit Care Med 33: 440-449.
35. Kortmann GL, Dobler CJ, Bizarro L, Bau CH (2010) Pharmacogenetics of smoking cessation therapy. Am J Med Genet B Neuropsychiatr Genet 153B: 17-28.
36. Erlich H (2012) HLA DNA typing: past, present, and future. Tissue Antigens 80: 1-11.
37. Sano Y, Date H, Nagahiro I, Aoe M, Shimizu N (2005) Relationship between anti-ABO antibody production and hemolytic anemia after minor ABOmismatched living-donor lobar lung transplantation. Transplant Proc 37: 1371-1372.
38. Smits JM, Vanhaecke J, Haverich A, de Vries E, Smith M, et al. (2003) Threeyear survival rates for all consecutive heart-only and lung-only transplants performed in Eurotransplant, 1997-1999. Clin Transpl: 89-100.
39. Papa V, Vaccarezza M (2013) Teaching Anatomy in the XXI Century: New Aspects and Pitfalls. Scientific World Journal 2013: 310348.
40. van Moorsel CH, van Oosterhout MF, Barlo NP, de Jong PA, van der Vis JJ, et al. (2010) Surfactant protein C mutations are the basis of a significant portion of adult familial pulmonary fibrosis in a dutch cohort. Am J Respir Crit Care Med 182: 1419-1425.
41. Campo I, Zorzetto M, Mariani F, Kadija Z, Morbini P, et al. (2014) A large kindred of pulmonary fibrosis associated with a novel ABCA3 gene variant. Respir Res 15: 43.
42. Aquino-Galvez A, Perez-Rodriguez M, Camarena A, Falfan-Valencia R, Ruiz V, et al. (2009) MICA polymorphisms and decreased expression of the MICA receptor NKG2D contribute to idiopathic pulmonary fibrosis susceptibility. Hum Genet 125: 639-648.
43. Selman M, Lin HM, Montano M, Jenkins AL, Estrada A, et al. (2003) Surfactant protein A and B genetic variants predispose to idiopathic pulmonary fibrosis. Hum Genet 113: 542-550.
44. Wang Y, Kuan PJ, Xing C, Cronkhite JT, Torres F, et al. (2009) Genetic defects in surfactant protein A2 are associated with pulmonary fibrosis and lung cancer. Am J Hum Genet 84: 52-59.
45. Guillot L, Epaud R, Thouvenin G, Jonard L, Mohsni A, et al. (2009) New surfactant protein C gene mutations associated with diffuse lung disease. J Med Genet 46: 490-494.
46. Cameron HS, Somaschini M, Carrera P, Hamvas A, Whitsett JA, et al. (2005) A common mutation in the surfactant protein C gene associated with lung disease. J Pediatr 146: 370-375.
47. Abou Taam R, Jaubert F, Emond S, Le Bourgeois M, Epaud R, et al. (2009) Familial interstitial disease with I73T mutation: A mid- and long-term study. Pediatr Pulmonol 44: 167-175.
48. Ono S, Tanaka T, Ishida M, Kinoshita A, Fukuoka J, et al. (2011) Surfactant protein C G100S mutation causes familial pulmonary fibrosis in Japanese kindred. Eur Respir J 38: 861-869.
49. Nogee LM, Dunbar AE 3rd, Wert SE, Askin F, Hamvas A, et al. (2001) A mutation in the surfactant protein C gene associated with familial interstitial lung disease. N Engl J Med 344: 573-579.
50. Thomas AQ, Lane K, Phillips J, 3rd, Prince M, Markin C, et al. (2002) Heterozygosity for a surfactant protein C gene mutation associated with usual interstitial pneumonitis and cellular nonspecific interstitial pneumonitis in one kindred. Am J Respir Crit Care Med 165: 1322-1328.
51. Tsakiri KD, Cronkhite JT, Kuan PJ, Xing C, Raghu G, et al. (2007) Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci U S A 104: 7552-7557.
52. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, et al. (2007) Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med 356: 1317-1326.
53. Fernandez BA, Fox G, Bhatia R, Sala E, Noble B, et al. (2012) A Newfoundland cohort of familial and sporadic idiopathic pulmonary fibrosis patients: clinical and genetic features. Respir Res 13: 64.
54. Marrone A, Sokhal P, Walne A, Beswick R, Kirwan M, et al. (2007) Functional characterization of novel telomerase RNA (TERC) mutations in patients with diverse clinical and pathological presentations. Haematologica 92: 1013-1020.